Inhaled Drug Delivery Annual Conference (London, United Kingdom - November 13th-14th, 2017)

Industry case studies, regulatory updates, latest therapies and technology innovations
Comunicato Precedente

next
Comunicato Successivo

next
Preferisci Informazione.News su Google

Industry case studies, regulatory updates, latest therapies and technology innovations

This annual conference includes presentations on each of the four principal technologies of inhaled drug delivery - dry powder inhalers, metered dose inhalers, nebulizers and liquid inhalers. It will also cover the future European and UK regulatory processes following Brexit, which will be critical when developing product approval strategies in the future.

There are a number of key areas that are currently evolving and the latest thinking and progress on these will also be presented, including Human factor design and sensing/connecting technologies. These key evolving areas are subject to much debate and require careful consideration whilst developing an inhaled drug product.

Programme to include:

Reasons to attend

Companies Participating include:

For more information about this conference visit https://www.researchandmarkets.com/research/8xbzxk/inhaled_drug

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 

Per maggiori informazioni

Ufficio Stampa

 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom

Allegati
Slide ShowSlide Show
Non disponibili
;